StemCells, Inc. to Participate at the 17th Annual BIO CEO & Investor Conference
02. Februar 2015 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Feb. 2, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Management will make a presentation on the Company's programs and operations at the 17th Annual BIO...
Stem Cells Inc. Posts Letter to Shareholders
26. Januar 2015 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Jan. 26, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system,...
StemCells, Inc. Transplants First Participant in Phase II Clinical Trial in Cervical Spinal Cord Injury
18. Dezember 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the central...
StemCells, Inc. Hosts Leading Biotech Investors and Analysts at Inaugural Event
02. Dezember 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Dec. 2, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leader in the development of cell-based therapies for disorders of the central nervous system (CNS), hosted its first...
StemCells, Inc. to Host Inaugural Investor and Analyst Event in New York
20. November 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Nov. 20, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), who pioneered the discovery and development of HuCNS-SC® cells, a proprietary population of highly purified,...
StemCells, Inc. Reports Third Quarter 2014 Financial and Operating Results
05. November 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Nov. 5, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), which pioneered the discovery and development of HuCNS-SC® cells, a proprietary population of highly purified,...
StemCells, Inc. to Host Inaugural Investor and Analyst Event in New York
03. November 2014 17:25 ET
|
StemCells, Inc.
NEWARK, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), who pioneered the discovery and development of HuCNS-SC® cells, a proprietary population of highly purified,...
StemCells, Inc. Initiates Phase II Clinical Trial in Cervical Spinal Cord Injury
07. Oktober 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Oct. 7, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell based therapies for the treatment of disorders of the central...
StemCells, Inc. to Participate at the 2014 Stem Cell Meeting on the Mesa
01. Oktober 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Oct. 1, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will make a presentation on the Company's programs and operations...
StemCells, Inc. to Participate at the 16th Annual Rodman & Renshaw Global Investment Conference
04. September 2014 16:05 ET
|
StemCells, Inc.
NEWARK, Calif., Sept. 4, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will present at the 16th Annual Rodman & Renshaw Global Investment Conference...